This compound is primarily used in organic synthesis, particularly in Suzuki-Miyaura cross-coupling reactions, where it acts as a boronic acid reagent to form carbon-carbon bonds. Its structure, featuring a tert-butoxycarbonyl (Boc) protected piperazine group and a trifluoromethylphenyl moiety, makes it valuable in the development of pharmaceutical intermediates. The Boc group provides stability during reactions and can be easily deprotected to yield free piperazine, which is a common pharmacophore in drug design. The trifluoromethyl group enhances the compound's lipophilicity and metabolic stability, making it useful in the synthesis of bioactive molecules, including potential drug candidates targeting various diseases. Its application is particularly relevant in medicinal chemistry for the preparation of complex organic molecules with potential therapeutic properties.